Clinical Trial Update: Personalized Multi-peptide Vaccination in CLL Patients [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 trial evaluating a personalized multi-peptide vaccination in patients with chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Personalized Multi-peptide Vaccination

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED